Optimal Medical Care

DRUG3 trials

Sponsors

Radboud University Medical Center, First Affiliated Hospital of Harbin Medical University, Nuvaira, Inc.

Conditions

AtherosclerosisCOPDCardiovascular DiseasesDepressive Disorder, MajorPeripheral Arterial Disease

Phase 1

Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication

WithdrawnNCT03318484

First Affiliated Hospital of Harbin Medical UniversityAtherosclerosis, Cardiovascular Diseases, Peripheral Arterial Disease

Start: 2017-11-30End: 2019-11-30Updated: 2021-08-23

Unknown Phase

Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression

CompletedNCT00928980

Radboud University Medical CenterDepressive Disorder, Major

Start: 2009-05-31End: 2013-06-30Updated: 2020-11-13

Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Active, not recruitingNCT03639051

Nuvaira, Inc.COPD

Start: 2019-05-23End: 2028-09-30Updated: 2024-11-14

Related Papers

Randomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3).

2025-12-013 citations

Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers

BMJ Open2020-11-0116 citations

Pre-treatment lung function decline stabilizes up to 3 year after targeted lung denervation in COPD

2020-09-072 citations

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3).

2020-02-1320 citations

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial

American Journal of Respiratory and Critical Care Medicine2019-08-1268 citations

Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.

2016-02-1838 citations

Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.

2012-08-2729 citations